EAP-derived monoclonal antibodies for "wish list" hamster immune targets involved in cell activation.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93021C00056
- Awardee
-
Silver Lake Research Corporation UEI C9FZMJCTQFP4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $600,000
Award facts
- Opportunity
-
- PHS202101 Solicitation number
- Contract value 100% obligated
- $600,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 10 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Irwindale, CA, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $600,000 |
About this award
Silver Lake Research Corporation, doing business as Silver Lake Research Corp., has been awarded a firm fixed price definitive contract valued at $600,000 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this contract, Silver Lake will deliver EAP-derived monoclonal antibodies for immune targets involved in cell activation in hamsters, as requested in the original solicitation. The prime contractor will perform work in Irwindale, California. With a period of performance from August 2021 through July 2023, this total small business set-aside contract aims to support the NIH's efforts to study immune responses.
Quick answers
Who was awarded contract 75N93021C00056?
75N93021C00056 was awarded to Silver Lake Research Corporation by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2021.
How much is contract 75N93021C00056 worth?
The government has obligated $600,000 on 75N93021C00056.
Was contract 75N93021C00056 competed?
The extent of competition for 75N93021C00056 was full and open competition after exclusion of sources. The government received 10 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award